Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non Operating Investment Income (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Non Operating Investment Income for 4 consecutive years, with $15000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income rose 108.52% to $15000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8000.0 through Dec 2025, up 111.76% year-over-year, with the annual reading at $8000.0 for FY2025, 111.76% up from the prior year.
  • Non Operating Investment Income for Q4 2025 was $15000.0 at Orchestra BioMed Holdings, down from $29000.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $1.7 million in Q2 2022, with the low at -$314000.0 in Q3 2022.
  • Average Non Operating Investment Income over 4 years is $38000.0, with a median of -$18000.0 recorded in 2024.
  • The sharpest move saw Non Operating Investment Income skyrocketed 536.84% in 2024, then tumbled 850.0% in 2025.
  • Over 4 years, Non Operating Investment Income stood at -$165000.0 in 2022, then crashed by 78.18% to -$294000.0 in 2023, then surged by 40.14% to -$176000.0 in 2024, then surged by 108.52% to $15000.0 in 2025.
  • According to Business Quant data, Non Operating Investment Income over the past three periods came in at $15000.0, $29000.0, and -$21000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.